Cerebrospinal fluid tau levels increase with age in healthy individuals

Dementia and Geriatric Cognitive Disorders

Volumn 12, Issue 2, 2001, Pages 127-132

  Blomberg, Mari ^a   Jensen, Malene ^a   Basun, Hans ^a   Lannfelt, Lars ^a   Wahlund, Lars Olof ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Apolipoprotein E genotype; Cerebrospinal fluid; Tau protein

Indexed keywords

APOLIPOPROTEIN E; TAU PROTEIN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID EXAMINATION; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; NERVE DEGENERATION; NORMAL HUMAN; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

AGED; AGED, 80 AND OVER; AGING; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; BRAIN; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; TAU PROTEINS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0035121581     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051246     Document Type: Article

References (32)

1. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme linked immunoabsorbant assay
2. Increased cerebrospinal fluid tau in patients with Alzheimer's disease
3. Tau in cerebrospinal fluid: Establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau
4. Increased levels of tau protein in cerebrospinal fluid of patients with Alzheimer's disease
5. Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease
6. Tau protein concentration in cerebrospinal fluid of patients with dementia of Alzheimer type
7. Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease
8. Reduction of β-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer's disease
9. Tau protein in cerebrospinal fluid, a biochemical marker for axonal degeneration in Alzheimer's disease?
10. Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele epsilon 4 during 14 months follow-up
11. Cerebrospinal fluid tau is elevated in early Alzheimer's disease
12. Elevated levels of tau in cerebrospinal fluid: Implications for the antemortem diagnosis of Alzheimer's disease
13. Alterations in tau protein metabolism during normal aging
14. Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40 and Aβ1-42(43) in Alzheimer's disease: A study in Japan
15. Lack of association between apolipoprotein E allele epsilon 4 and sporadic Alzheimer's disease
16. Dependence of cerebrospinal fluid tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease
17. CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease
18. Mini mental state: A practical method for grading the cognitive state of patients for the clinician
19. APO E polymorphism is not a risk factor for cognitive impairment and haemorrhagic stroke from age 75 onwards
20. Principles of albumin and IgG analyses in neurological diseases, establishment of reference values
21. Cerebrospinal fluid levels of amyloid β-protein in Alzheimer's disease: Inverse correlation with severity of dementia and effect of apolipoprotein E genotype
22. Elevation of microtubule-associated protein tau in the cere-brospinal fluid of patients with Alzheimer's disease
23. Age-associated memory impairment: Proposed diagnostic criteria and measures of clinical change - Report of a National Institute of Mental Health Work Group
24. Cell counts in human cerebral cortex in normal adults throughout life using an image analysing machine
25. Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease
26. A new clinical scale for the staging of dementia
27. Functional staging of dementia of the Alzheimer type
28. Apolipoprotein E genotyping and cerebrospinal fluid tau protein: Implications for the clinical diagnosis of Alzheimer's disease
29. Tau proteins in cerebrospinal fluid from patients with Alzheimer's disease: A longitudinal study
30. Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer's disease
31. Apolipoprotein E4 accelerates dementia and increases cerebrospinal fluid tau levels in Alzheimer's disease
32. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer's disease